Date | Company Name | Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|---|
Dec 1, 2022 | Carrick Therapeutics | Series C | — | Biotechnology | — |
Nov 29, 2022 | Cajal Neuroscience | Series A | — | Biotechnology | — |
May 3, 2022 | Tubulis | Series B | — | Biotechnology | — |
Feb 16, 2022 | Centauri Therapeutics | Series A | — | Biotechnology | — |
Feb 15, 2022 | IMIDomics | Corporate Round | — | Biotechnology | Yes |
Aug 18, 2021 | Immunitas Therapeutics | Series B | — | Biotechnology | — |
Jul 29, 2021 | Topas Therapeutics | Series B | — | Advanced Materials | — |
Apr 21, 2021 | OxVax | Seed | — | Biotechnology | Yes |
Mar 4, 2021 | Exscientia | Series C | — | Artificial Intelligence | — |
Mar 2, 2021 | ARGOBIO | Funding Round | — | Biotechnology | — |
Jan 8, 2021 | Blacksmith Medicines | Seed | — | Biotechnology | — |
Jun 24, 2020 | Autobahn Labs | Seed | — | Biotechnology | Yes |
May 26, 2020 | Exscientia | Series C | — | Artificial Intelligence | — |
Apr 16, 2020 | leon nanodrugs | Series B | — | Biotechnology | — |
Nov 22, 2019 | Immunitas Therapeutics | Series A | — | Biotechnology | — |
Jul 9, 2019 | Breakpoint Therapeutics | Series Unknown | — | Biotechnology | — |
Apr 1, 2019 | Celmatix | Series Unknown | — | Biotechnology | — |
Jan 7, 2019 | Exscientia | Series B | — | Artificial Intelligence | — |
Sep 28, 2017 | Exscientia | Series A | — | Artificial Intelligence | Yes |
Apr 25, 2017 | Forge Therapeutics | Series A | — | Biotechnology | — |
Jan 9, 2017 | Eternygen | Series A | — | Biotechnology | — |
Oct 3, 2016 | Carrick Therapeutics | Series A | — | Biotechnology | — |
Dec 2, 2014 | Sanofi | Post-IPO Equity | — | Health Care | Yes |